Majeed syndrome is a rare genetic condition that causes recurrent bone inflammation and skin problems. It usually starts in infancy and continues lifelong, with flares that come and go. Many people with Majeed syndrome have painful swollen bones, fevers, and sometimes anemia that leads to fatigue and pallor. Treatment focuses on controlling inflammation with medicines such as NSAIDs, corticosteroids, or biologic drugs, and managing anemia. The outlook varies, but with specialist care many people with Majeed syndrome can reduce flares and complications.
Overview
Majeed syndromeSymptoms
Key features of Majeed syndrome include repeated bone pain and swelling from inflammatory bone lesions, usually starting in infancy. Many also have pallor and tiredness from anemia and may develop tender, red skin patches. Fevers and poor growth can occur.
Outlook and prognosis
Most people with Majeed syndrome live with symptoms that flare and ease over time, especially in childhood. With early diagnosis, anti‑inflammatory care, infection prevention, and close monitoring of growth and anemia, daily life often becomes more predictable. Some improve markedly with targeted treatments from an immunology or rheumatology team.
Causes and risk factors
Majeed syndrome results from inheriting two faulty LPIN2 gene copies (autosomal recessive). Risk rises when both parents are carriers, especially in consanguineous families. Environment doesn’t cause it, but infections or stress may influence flares and severity.
Genetic influences
Genetics is central to Majeed syndrome: it’s caused by inherited changes in the LPIN2 gene. Most cases follow an autosomal recessive pattern, so both parents typically carry one variant. Specific variants can influence age at onset and symptom severity.
Diagnosis
Doctors suspect Majeed syndrome when infants have recurrent bone inflammation, anemia, and skin findings. Diagnosis is confirmed with genetic tests and supportive imaging or labs. Early genetic diagnosis of Majeed syndrome guides treatment and family counseling.
Treatment and drugs
Treatment for Majeed syndrome focuses on calming inflammation, easing pain, and supporting growth and mobility. Doctors often use anti‑inflammatory medicines, disease‑modifying drugs like IL‑1 blockers (such as anakinra or canakinumab), and tailored antibiotics when bone infections are suspected. Care usually includes physical therapy, iron management for anemia, and regular monitoring by rheumatology, hematology, and orthopedics.
Symptoms
In many children, the first clues are bone pain, fevers, tiredness from anemia, and skin changes. Features vary from person to person and can change over time. Parents may spot early features of Majeed syndrome in infancy or early childhood, such as limping or unusually pale skin. Flares often alternate with quieter periods when things briefly improve.
Achy, tender bones—often in the legs, pelvis, or ribs—can swell and feel warm, and the pain may worsen with activity. Clinicians call this chronic recurrent multifocal osteomyelitis, which means repeated inflammation in several bones. In Majeed syndrome, these episodes can start early in childhood.
Trouble putting weight on a leg or stiff hips, knees, or ankles can change the way a child walks. Mornings or after rest may feel especially stiff.
Fevers often rise to 38–40°C (100.4–104°F) during flares and can come with chills or a general unwell feeling. They may appear even when no infection is found.
Low red blood cells can cause unusual tiredness, pale skin, and low stamina in Majeed syndrome. Some feel short of breath with play or have a fast heartbeat with mild activity.
How people usually first notice Majeed syndrome?
Many families first notice the first signs of Majeed syndrome in infancy or early childhood when a baby has repeated, unexplained fevers and becomes very irritable, often alongside painful swelling in the long bones that makes a child refuse to move a limb. Doctors are often alerted by episodes of sterile multifocal osteomyelitis (bone inflammation without infection), a persistent anemia that can make a child look pale and tired, and sometimes a scaly, red skin rash; these features together prompt genetic testing of LPIN2. For many, how Majeed syndrome is first noticed is this triad—recurrent bone pain and swelling, chronic anemia, and inflammatory skin changes—appearing early and recurring despite antibiotics.
Types of Majeed syndrome
Majeed syndrome is a rare genetic condition, and there aren’t many distinct clinical variants recognized. Most people share the same core features, but severity and timing can vary even within families. Symptoms don’t always look the same for everyone. When people look for types of Majeed syndrome, they’re usually asking how the condition can present differently, such as earlier versus later onset or milder versus more severe courses.
Classic phenotype
This includes recurring bone inflammation, a blood anemia that starts early, and sometimes a psoriasis-like skin rash. Symptoms often begin in infancy or early childhood and can flare in cycles. Pain, fevers, and trouble with everyday activities during flares are common.
Atypical/milder course
Some have fewer bone flares, milder anemia, or later onset. Day-to-day life may be less disrupted, with longer calm periods between episodes. Not everyone will experience every type.
Early-onset severe
Symptoms appear in infancy with frequent flares, significant anemia, and growth impact. Hospital care may be needed during bad episodes. Loved ones may recognize certain types sooner than the person experiencing them.
What genetics can tell you about symptoms
In Majeed syndrome, changes in the LPIN2 gene disrupt how certain immune cells calm inflammation, leading to repeating fevers, painful bone swelling (chronic recurrent multifocal osteomyelitis), and severe anemia. Different LPIN2 variants can shift severity and timing, especially of bone pain and flare frequency.
Causes and risk factors
Majeed syndrome is caused by changes in the LPIN2 gene inherited from both parents. It follows an autosomal recessive pattern, so each child of two carriers has a 25% (1 in 4) chance to be affected. Risk is higher in families with known carriers or when parents are related by blood. Environment and lifestyle do not cause it, but illnesses or physical stress can trigger flares. Genetic testing can sometimes clarify your personal risk.
Environmental and biological risk factors
Risk for Majeed syndrome appears to come mainly from biology present from birth rather than outside exposures. Doctors often group risks into internal (biological) and external (environmental). So far, research has not identified environmental causes that raise the chance of Majeed syndrome. The points below reflect what is and isn’t known about environmental or biological influences on who develops the condition, and they do not appear to change the early symptoms of Majeed syndrome.
Studies to date have not shown older maternal or paternal age to raise the chance of Majeed syndrome. Most cases do not track with parental age.
Common pregnancy conditions such as diabetes, infections, or high blood pressure have not been linked to higher risk of Majeed syndrome. Current evidence does not support an association.
Exposure during pregnancy to radiation, heavy metals, or hormone-disrupting chemicals has not been shown to affect the likelihood of this condition. No specific environmental exposure has a proven role.
Prematurity, birth complications, or mode of delivery do not appear to change the chance of being born with this condition. These factors more often affect newborn health after birth rather than the condition itself.
Genetic risk factors
The genetic causes of Majeed syndrome center on changes in a single inflammation-control gene called LPIN2. This condition follows an autosomal recessive pattern, meaning a child typically needs two LPIN2 changes—one from each parent—to develop it. Some risk factors are inherited through our genes. Families can use carrier testing to understand recurrence risk and plan for future pregnancies.
LPIN2 gene changes: Harmful changes in the LPIN2 gene disrupt a protein that helps calm the body’s inflammation. When both copies of LPIN2 are altered, Majeed syndrome can develop. This is the core genetic cause of the condition.
Autosomal recessive inheritance: A child typically must inherit one LPIN2 change from each parent to develop Majeed syndrome. People who carry a single change are usually healthy carriers. This pattern is known medically as autosomal recessive.
Carrier parent risk: If both parents carry one LPIN2 change, each pregnancy has a 25% chance of Majeed syndrome, a 50% chance of a carrier child, and a 25% chance of neither change. These probabilities are the same in every pregnancy. They apply equally to boys and girls.
Shared ancestry clusters: In some families or communities with shared ancestry, the same LPIN2 change may be more common because it was passed down over generations. This can raise the chance that two carriers meet and have a child together. Clustering does not mean the condition is limited to any one group.
Parental relatedness: Parents who are related by blood, such as cousins, are more likely to carry the same rare LPIN2 change. This increases the chance a child inherits two changes and develops the condition. Genetic counseling can help families understand these specific risks.
Variable expression: People with the same LPIN2 changes can have different ages at onset and different levels of severity. Some develop signs very early in infancy, while others are recognized later. This variability is part of how recessive conditions can present.
Genetic testing: Testing can confirm LPIN2 changes in someone with suggestive features and identify carriers in the family. In some cases, genetic testing can give a clearer picture of your personal risk. Results can also guide options for future pregnancies.
Lifestyle risk factors
Majeed syndrome is a genetic autoinflammatory condition; lifestyle habits do not cause it, but they can influence symptom severity, flare frequency, and long-term complications. Thoughtful daily choices may help reduce bone inflammation and pain, support anemia-related fatigue, and protect growth and mobility. Below are practical ways for how lifestyle affects Majeed syndrome, focused on elements patients can control. These reflect lifestyle risk factors for Majeed syndrome rather than its genetic origins.
Regular low-impact movement can maintain joint range and muscle support around inflamed bones in chronic recurrent multifocal osteomyelitis. High-impact or contact activities may aggravate bone pain or trigger flares.
Planning rest between tasks can prevent overloading painful bone sites and reduce post-exertional flares. Short, frequent activity blocks are often better tolerated than long sessions.
Emphasizing whole foods, fruits, vegetables, legumes, nuts, and omega-3–rich fish may modestly dampen systemic inflammation that worsens bone and skin symptoms. Limiting ultra-processed foods and added sugars can help stabilize inflammatory swings.
Sufficient protein supports growth and tissue repair in children managing chronic bone inflammation. Inadequate intake can slow recovery from flares and worsen fatigue.
Risk prevention
Majeed syndrome is a rare inherited condition, so there’s no way to fully prevent it, but you can lower the chance of complications and flares. Day to day, prevention focuses on vaccinations, prompt care for fevers, steady anti‑inflammatory treatment, and close monitoring of bones, blood, and growth. Prevention is about lowering risk, not eliminating it completely. Learning the early symptoms of Majeed syndrome—such as repeated bone pain, fevers, and unusual tiredness—can help you seek care sooner.
Meet with a genetics team to understand inheritance, carrier testing, and family planning options. They can discuss prenatal testing or embryo testing to reduce the chance of Majeed syndrome in future pregnancies.
Keep routine vaccines current to reduce infections that can trigger fevers and bone flares. Ask about extra protection like flu and pneumonia shots if your care team recommends them.
Treat fevers and suspected infections early to limit stress on the body. Have a plan with your doctor for when to call, what tests to get, and when to start antibiotics.
Take prescribed anti‑inflammatory medicines consistently to prevent or shorten flares. Do not stop or change doses without checking with your specialist.
Transmission
Majeed syndrome is not infectious—you can’t catch it from someone or pass it through everyday contact. It’s a genetic condition passed down in an autosomal recessive pattern. This means both parents are usually healthy carriers, and with each pregnancy there is a 25% (1 in 4) chance the child will have Majeed syndrome, a 50% (1 in 2) chance the child will be a carrier, and a 25% (1 in 4) chance the child will inherit neither change. If there’s no known family history, how Majeed syndrome is inherited can still involve silent carrier parents, and genetic counseling can help clarify carrier status.
When to test your genes
Consider genetic testing if you have recurrent bone inflammation (chronic recurrent multifocal osteomyelitis), growth problems, or unexplained anemia—especially with a family history or parents from related families. Testing is also reasonable before pregnancy or early in a child’s life when symptoms begin. Results can confirm diagnosis, guide IL‑1–blocking treatment, and inform family planning.
Diagnosis
Majeed syndrome is usually suspected when a child has repeated bone pain and swelling, unexplained anemia, and sometimes a neutrophilic skin rash that keeps coming back. Day to day, this can look like limping after short walks, waking at night with deep bone aches, or seeming unusually tired and pale. The genetic diagnosis of Majeed syndrome is usually confirmed with a DNA test that looks for changes in the LPIN2 gene. Getting a diagnosis is often a turning point toward answers and support.
Doctors look for a pattern of recurring bone pain and swelling, fevers, skin changes, and signs of anemia such as pallor or fatigue. The combination of bone inflammation with ongoing anemia raises suspicion for Majeed syndrome.
Inflammation markers are often elevated, and testing commonly shows a persistent anemia. Blood counts and a blood smear can point toward a specific type of anemia that fits this condition.
MRI, sometimes of the whole body, can spot multiple areas of bone inflammation even when X‑rays look normal. Finding several active sites without signs of infection supports the diagnosis.
A small sample from an affected bone can help rule out bacterial infection or cancer. Results often show sterile inflammation rather than an infection that would grow on culture.
Stages of Majeed syndrome
Majeed syndrome does not have defined progression stages. Symptoms tend to flare and settle over time, and the mix of bone pain, anemia, and skin changes can vary widely from child to child. Different tests may be suggested to help confirm the diagnosis and track inflammation. Clinicians often use your history and exam together with blood counts and inflammation markers, MRI of painful bones, and, when appropriate, genetic testing for LPIN2; early symptoms of Majeed syndrome are often noticed in childhood.
Outlook and prognosis
Looking at the long-term picture can be helpful. Majeed syndrome can be lifelong, but the outlook varies a lot from child to child. Many living with Majeed syndrome have flare‑ups of bone pain and swelling that come and go, with stretches of calmer periods in between. For some, early symptoms of Majeed syndrome begin in infancy with fevers and difficulty gaining weight; with time and treatment, growth and daily routines often improve. Severe anemia can add fatigue and shortness of breath, but targeted care—like anti‑inflammatory medicines, steroid‑sparing drugs, treatment for anemia, and nutrition support—often reduces hospital visits and helps kids stay active in school and play.
Prognosis refers to how a condition tends to change or stabilize over time. Infections are not the driver; instead, ongoing inflammation can affect bones and, less often, the liver or other organs. With regular monitoring and prompt treatment of flares, many people maintain good function and avoid lasting bone damage, though some may develop limb length differences or joint stiffness over years. Mortality appears low with modern care, but serious complications can arise if inflammation and anemia go untreated, especially in very young children.
Genetic testing can sometimes provide more insight into prognosis. Changes in the LPIN2 gene underlie Majeed syndrome, but not everyone with the same gene change will have the same outlook, and response to medication can differ. Talk with your doctor about what your personal outlook might look like. Keep regular appointments—small adjustments can improve long-term health.
Long-term effects
Majeed syndrome tends to have a lifelong pattern of inflammation that mainly affects bones, blood, and skin. Long-term effects vary widely, and can change from childhood into adulthood. Some early symptoms of Majeed syndrome, like bone pain and fevers, may ease during quiet periods, while other features can leave lasting changes. Overall outlook depends on how often flares occur and how strongly the body’s inflammation is switched on.
Ongoing sterile bone inflammation can come in waves, bringing pain and tenderness in the same or new spots. Over time, repeated flares can limit physical activity and day-to-day routines.
Inflammation around growth plates can slow or disrupt bone growth, sometimes leading to limb-length differences. Spine or long-bone involvement may cause mild deformity and changes in posture or gait.
Nearby joints can become irritated from recurrent bone inflammation, leading to stiffness and reduced range of motion. Over years, some develop early joint wear that makes certain movements harder.
Majeed syndrome often includes ongoing red blood cell changes that cause anemia, with tiredness, pale skin, and sometimes yellowing of the eyes. The spleen may enlarge, and energy levels can stay lower than expected between flares.
How is it to live with Majeed syndrome?
Living with Majeed syndrome often means cycling between periods of painful bone inflammation and fatigue, with flare‑ups disrupting school, work, and sleep. Many find daily routines shaped by medical visits, medications, and planning around pain, while anemia can add shortness of breath and low energy on even ordinary days. Families and caregivers may shoulder extra logistics and emotional load, coordinating care and offering support during flares, and siblings may notice plans changing at the last minute. With a knowledgeable care team, clear pain plans, and support at home and school, many people build steady routines that help them stay engaged in life despite the unpredictability.
Treatment and drugs
Majeed syndrome is treated by calming the overactive inflammation that drives bone pain, fevers, and skin symptoms, while also supporting growth and nutrition. Nonsteroidal anti-inflammatory drugs (NSAIDs) and short courses of corticosteroids may ease flares, but many people need medicines that more directly block the inflammatory signals, such as biologics that target interleukin-1; these can reduce fevers, bone inflammation, and anemia. If infections are suspected, doctors will treat them promptly, and some children need iron support, transfusions, or erythropoietin for anemia; physical therapy helps maintain mobility during and after painful episodes. Supportive care can make a real difference in how you feel day to day. Your doctor can help weigh the pros and cons of each option, and adjust treatment over time based on symptoms, side effects, and response.
Non-drug treatment
Living with Majeed syndrome often means navigating bone pain, skin flares, fatigue, and school or work disruptions. Alongside medicines, non-drug therapies can help you stay active, protect joint function, and ease day‑to‑day symptoms. A team-based plan also makes it easier to spot early symptoms of Majeed syndrome and act before a flare escalates. The ideas below are commonly used and can be tailored to age, symptoms, and personal goals.
Gentle, guided exercises help maintain strength and joint range. Therapists can pace activity to avoid flare triggers. They can also teach safe movement during painful spells.
Practical techniques make daily tasks less painful and more efficient. Therapists may suggest joint-sparing methods for dressing, writing, or cooking. They can recommend tools that reduce strain on sore hands or limbs.
Warm packs can relax tight muscles and soothe stiffness. Cold packs may calm hot, tender areas during flares. Limit skin contact time and use a cloth barrier to protect skin.
Low-impact movement like walking, swimming, or cycling maintains fitness without pounding the bones. Short, regular sessions often beat long, intense workouts. Rest days can be built in around flares.
Your genes may have an impact on how drugs work for you
Medicines for Majeed syndrome, especially those calming inflammation, can work differently depending on gene changes that affect immune signaling and drug processing. Genetics may guide dose, predict side effects, and suggest alternatives if standard treatments don’t control flares.
Pharmacological treatments
Treatment for Majeed syndrome focuses on calming the body’s overactive inflammation and managing anemia and bone pain. When early symptoms of Majeed syndrome flare in childhood, doctors often start with medicines that quickly reduce inflammation, then move to longer-acting options to keep it controlled. Not everyone responds to the same medication in the same way. Safety monitoring and vaccines are important when using immune-calming drugs.
Anakinra and canakinumab lower the specific immune signal (IL‑1) that drives inflammation in Majeed syndrome. They can ease bone pain and skin flares and reduce hospital visits. Rilonacept is another option in some cases.
Prednisone or prednisolone can quickly calm painful bone inflammation and fever during flares. They’re usually used short term because long-term use can cause weight gain, high blood pressure, and bone thinning.
Ibuprofen or naproxen may help with day-to-day bone pain and swelling. These are often add-on treatments but may not fully control the condition by themselves.
Pamidronate or zoledronic acid can reduce bone pain and inflammation when flares are frequent. They are given by infusion at intervals and require kidney and mineral monitoring.
Genetic influences
In Majeed syndrome, harmful changes in a gene called LPIN2 are the root cause. The condition is inherited in an autosomal recessive way, meaning a child needs two changed copies—one from each parent—to develop it. A “carrier” means you hold the gene change but may not show symptoms. When both parents are carriers, each pregnancy has a 25% chance of a child having Majeed syndrome, a 50% chance the child will be a carrier, and a 25% chance of neither copy changed. Genetic testing for Majeed syndrome can identify LPIN2 variants and confirm the diagnosis in an affected person, and it can check whether parents or siblings carry the same change. Because rare gene changes can be shared within extended families—especially when parents are related by blood—speaking with a genetic counselor can help you understand risks and plan next steps.
Is Majeed syndrome genetic?
Genetics is central to Majeed syndrome: it’s caused by inherited changes in the LPIN2 gene. Most cases follow an autosomal recessive pattern, so both parents typically carry one variant. Specific variants can influence age at onset and symptom severity.
Pharmacogenetics—how genetics influence drug effects
Because Majeed syndrome is driven by changes in the LPIN2 gene, treatment often focuses on calming the overactive inflammation those changes trigger. Confirming the genetic cause can steer doctors toward targeted medicines that block interleukin‑1 (IL‑1), such as anakinra or canakinumab, which have helped many people with Majeed syndrome. Even if early symptoms of Majeed syndrome look like other bone or skin inflammation, the genetic result helps distinguish it and supports using IL‑1 blockers rather than cycling through less specific drugs. Not every difference in response is genetic, but pharmacogenetic testing may help tailor common add‑on medicines, such as certain anti‑inflammatory pain relievers or codeine‑type pain medicines, to reduce side effects and improve pain control. There isn’t a known gene result that changes the dose of IL‑1 blockers themselves, so dosing is usually based on age, weight, and how well symptoms are controlled. Because Majeed syndrome is rare, your care team will often personalize therapy over time, combining your genetic diagnosis with close monitoring to adjust medicines safely.
Interactions with other conditions
Fevers, bone pain, and skin flares can look like infection, so when a true bacterial illness happens at the same time, it can be hard to tell what is driving symptoms. Early symptoms of Majeed syndrome, like sudden fevers and tender bones, often resemble bacterial osteomyelitis, so doctors typically test carefully before starting antibiotics or immune-calming medicines. Doctors call it a “comorbidity” when two conditions occur together, and in Majeed syndrome this matters because infections can trigger flares while also needing their own treatment. The chronic anemia that comes with Majeed syndrome can add strain if someone also has heart or lung disease, making fatigue, shortness of breath, or exercise intolerance more noticeable. Skin inflammation in Majeed syndrome may overlap with other neutrophil‑driven skin conditions, so combined rashes can appear worse and require coordinated dermatology and rheumatology care. Because Majeed syndrome is driven by overactive inflammation, its pathways overlap with other autoinflammatory diseases, and treatments that calm the IL‑1 pathway may help when conditions occur together.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described children with fevers that kept coming back, sore bones, and skin rashes that wouldn’t fully go away. Families sometimes noticed more than one child affected, while parents and grandparents were not—hinting at a hidden pattern. A toddler might limp off and on for weeks, then seem fine, only to wake at night with burning bone pain. In some communities, these stories were passed down as “the illness that returns with the seasons,” long before tests or scans were available.
From early clinical notes on unexplained bone inflammation in children, doctors gradually recognized a recurring pattern: periods of high fever, painful swelling in the long bones, and stubborn skin problems like psoriasis. Because bacterial infections can also cause fevers and bone pain, many children initially received courses of antibiotics that did little to help. Over time, descriptions became more precise, separating long-lasting, sterile bone inflammation from true infections. This careful observation led clinicians to suspect an autoinflammatory process—a body’s own immune system sparking inflammation without germs as the trigger.
First described in the medical literature as a cluster of symptoms found in related children, Majeed syndrome was later tied to changes in a single gene involved in how cells handle certain fats. This discovery helped explain why the bones, skin, and blood can all be involved. It also clarified why episodes begin early in life and why the condition tends to run in families when both parents carry the same silent change in the gene.
In recent decades, knowledge has built on a long tradition of observation. Genetic testing confirmed the link, and modern imaging showed bone inflammation even when standard X‑rays looked normal. Clinicians learned to look for a triad: chronic recurrent multifocal osteomyelitis (repeating hotspots of sterile bone inflammation), skin psoriasis or similar rashes, and anemia that doesn’t improve as expected. Not every child has all three features at the start, which is one reason early symptoms of Majeed syndrome were often missed.
Understanding the history of Majeed syndrome has changed care. Instead of repeated antibiotics and surgeries for suspected infections, many children now receive treatments that calm the overactive inflammatory pathways. Families with affected children can be offered genetic counseling to understand inheritance and plan future pregnancies. Although rare, Majeed syndrome is now recognized in diverse regions, reflecting both better awareness and wider access to genetic tools. Looking back helps explain why earlier reports seemed scattered; together they built the foundation for earlier diagnosis and more targeted therapy today.